Reversal of Dabigatran-Induced Anticoagulation
Dabigatran etexilate is a direct thrombin inhibitor widely used for stroke prevention in non-valvular atrial fibrillation and treatment of venous thromboembolism. While its predictable pharmacokinetics
Dabigatran etexilate is a direct thrombin inhibitor widely used for stroke prevention in non-valvular atrial fibrillation and treatment of venous thromboembolism. While its predictable pharmacokinetics
Acquired Factor VIII Deficiency, also known as acquired hemophilia A, is a rare but potentially life-threatening autoimmune disorder. It is characterized by the development of